Biotech Hangout

Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more
undefined
Oct 28, 2022 • 1h 1min

Episode 35

Rob Perez joins Daphne Zohar and Josh Schimmer to discuss the week's deals, data & FDA actions. Special guests include Kevin Judice, CEO of DiCE Therapeutics, and Alex Harding, who delves deeper into his recent Timmerman Report article on the Inflation Reduction Act.
undefined
Oct 25, 2022 • 1h

Episode 34

Hosts Josh Schimmer, Daphne Zohar and Tim Opler talk conflicts of interest in the industry, the Wall Street Journal’s investigation into the FTC and who regulates the regulators. Original air date:  October 14, 2022.
undefined
Oct 25, 2022 • 1h 2min

Episode 33

Hosts Daphne Zohar, Josh Schimmer and Bruce Booth discuss the recent rally in biotech and short interest stocks, when pharma doesn’t opt in or terminates a partnership, working with various divisions at the FDA and more. Original air date: October 7, 2022.
undefined
Oct 5, 2022 • 1h 16min

Episode 32

Paul Rennert, CEO, President and CSO of Aleta Biotherapeutics joins hosts Daphne Zohar, Brad Loncar and Chris Garabedian to discuss access to research and journal publications. Original air date: August 28, 2022.
undefined
Jun 9, 2021 • 1h 3min

Global Access Strategies: COVID Vaccines and Other Meds

This Biotech Clubhouse Session will cover insights into best practices for providing access to medicines in the developing from industry experts exploring learnings from Gilead Science’s HIV and Hepatitis C Access to Medicines Program. We take lessons from past efforts, look at the current COVID response, and discuss a path forward for low and middle-income countries’ access to COVID vaccines, as well as future life-saving medicines. Guests: Clifford Samuel, Claudio Lilienfeld, Kash Rangan. Host: Chris Garabedian.  Full auto-generated transcript: click here Originally aired on June 7th, 2021 on Biotech Clubhouse. Shared with permission       
undefined
Jun 9, 2021 • 1h 2min

Good is the New Cool with Afdhel Aziz

Companies can change the world for the better while advancing their own business goals by supporting community-building activities. Featuring Life Science Cares (LSC) Impact Breakfast Keynote Speaker, Afdhel Aziz, and hosted by LSC founder, Rob Perez. Originally aired May 27th on Biotech Clubhouse. Click here for transcript (autogenerated)
undefined
May 21, 2021 • 1h 2min

Pre-ASCO Discussion: Perspectives on Emerging Oncology Treatments

A cross-disciplinary group of oncology experts and a top wall street biotech analyst discuss the most promising new therapies presenting data at ASCO. Featuring Sally Church, James Gulley, Aleksandra Filipovic, and Umer Raffat. Moderated by Daphne Zohar. Originally aired May 21st on Biotech Clubhouse. Click for transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app